Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Change in Cash (2016 - 2025)

Historic Change in Cash for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to -$2.1 million.

  • Lipocine's Change in Cash fell 1836.64% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $158099.0, marking a year-over-year increase of 14794.29%. This contributed to the annual value of $1.4 million for FY2024, which is 1164.9% down from last year.
  • Latest data reveals that Lipocine reported Change in Cash of -$2.1 million as of Q3 2025, which was down 1836.64% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Lipocine's Change in Cash registered a high of $2.8 million during Q1 2022, and its lowest value of -$8.6 million during Q1 2021.
  • In the last 5 years, Lipocine's Change in Cash had a median value of -$941989.0 in 2023 and averaged -$1.1 million.
  • Per our database at Business Quant, Lipocine's Change in Cash crashed by 61702.74% in 2021 and then surged by 90687.7% in 2024.
  • Over the past 5 years, Lipocine's Change in Cash (Quarter) stood at -$1.6 million in 2021, then surged by 147.97% to $751536.0 in 2022, then fell by 6.98% to $699052.0 in 2023, then surged by 252.33% to $2.5 million in 2024, then plummeted by 187.01% to -$2.1 million in 2025.
  • Its last three reported values are -$2.1 million in Q3 2025, $2.7 million for Q2 2025, and -$2.9 million during Q1 2025.